ctx | 26000
beta-CrossLaps (C-telopeptides)
Keywords:
Bone metabolism
CTX
Osteopenia
Osteoporosis b-CrossLaps
antiresorptive therapy
beta-CrossLaps
bisphosphonates
bone loss
bone resorption
ß-Crosslaps
Status
| Material |
|
||
|---|---|---|---|
| Hint |
Fasting sample (12h abstention) in the morning between 07:30 – 08:30 h (circadian rhythm). |
||
| Min. volume | 500 µL | ||
| Stability |
Stability
1 day / 18-25°C
1 week / 2-8°C
3 months / -20°C
|
||
| Duration | 4 days | ||
| Frequency | 2 x per week | ||
| Method | Electrochemiluminescence Immunoassay (ECLIA) |
Price/Rate
| Price |
Price
CHF 33.30
|
|---|---|
| Rate |
Rate
33.30 TP
|
Reference values
| Value and unit | Age and unit | Sex |
|---|---|---|
| 0.15 - 0.97 µg/L | 0 - 29 Y | f |
| 0.15 - 0.64 µg/L | 30 - 39 Y | f |
| Premenop.:0.14-0.69 µg/L | >= 30 Y | f |
| Postmenop.:0.18-1.02 µg/L | >= 30 Y | f |
| 0.13 - 0.67 µg/L | 40 - 49 Y | f |
| 0.18 - 1.06 µg/L | 50 - 59 Y | f |
| 0.17 - 0.97 µg/L | 60 - 69 Y | f |
| 0.15 - 0.86 µg/L | >= 70 Y | f |
| 0.24 - 1.02 µg/L | 0 - 29 Y | m |
| 0.23 - 0.94 µg/L | 30 - 39 Y | m |
| 0.18 - 0.80 µg/L | 40 - 49 Y | m |
| 0.16 - 0.74 µg/L | 50 - 59 Y | m |
| 0.13 - 0.75 µg/L | 60 - 69 Y | m |
| 0.12 - 0.78 µg/L | >= 70 Y | m |
